manuscripts published during this period will not negatively impact on our assessment of the conceptual advance presented by your study. However, we request that you contact the editor as soon as possible upon publication of any related work, to discuss how to proceed. Should you foresee a problem in meeting this three-month deadline, please let us know in advance and we may be able to grant an extension.
Do not hesitate to contact me by e-mail or on the phone in case you have any questions.
Thank you for the opportunity to consider your work for publication. I look forward to your revision.
Yours sincerely, Editor
The EMBO Journal REFEREE REPORTS Referee #1
The authors have done a beautiful job on the regulation of function of claudin 16/19 by examining microRNA-mediated regulation for the level of expression claudin-14. I find the work interesting, as it provides a novel insight into the regulation of claudin function as calcium ion transporter. The work reported is of a level where the mechanism can be delineated and tested rigorously. This paper definitely goes beyond that of a typical descriptive paper and it is has reached the bar required for EMBO Journal.
I would like to add the following points to be considered for revision.
1. Introduction: The claudin family is now reported to consist of 27 members. Please correct the number 28 to 27 and refer the manuscript of FEBS letters, 2011 (Mineta et al.) . 2. The discussion on the pathway from CaSR to microRNA. 3. Figure 5 : How about the localization of claudin 16 and 19? 4. Figure 7 : Why is miR-9 significantly up-regulated when Ca2+ is increased in its concentration? 5. Why is the effect increased when mir-9 and mir-379 is co-transfected?
Referee #2
Previous GWAS analysis has identified the tight junction protein cldn14 as a risk factor for calcium dysregulation. In this manuscript the authors characterized the regulation of cldn14 by kidney. They found that cldn14 was expressed in the kidney, most prominently in the thick ascending limbs (TALs). Interestingly, cldn14 in the kidney appeared to be regulated by a combination of direct mRNA expression and at least two miRNAs. miRNA clearly contributes to cldn14 regulation. However the data in Figure 7A suggest that upregulation of cldn14 mRNA transcription is going to play a more dominant effect in regulation of cldn14 than miRNA. In particular, high calcium causes a 10-fold increase in cldn14 mRNA as opposed to a 50% decrease in miRNA.
Evidence presented indicates that regulation of cldn14 was controlled by serum calcium in vivo and in isolated cell models under control of the CaSR calcium sensing receptor. Cldn14 alters paracellular permeability in a kidney cell line model, LLC-PK1 cells, expressing exogenous cldn16 and cldn19. Biochemical data is presented suggesting that cldn14 interacts with cldn16, but not cldn19. While this partially addresses the mechanism of action for cldn14 to affect calcium transport, the study stops short of identifying how cldn14 alters cldn19 function when co-expressed with cldn16. Also, while cldn14 is shown to affect the electrophysiological properties of transfected LLC-PK1 cells and renal cldn14 in vivo is regulated in response to dietary/serum calcium, direct roles for cldn14 in renal calcium homeostasis in vivo are inferred, rather than directly measured. Specific Comments 1. Is renal calcium homeostasis affected in cldn14+/lacZ reporter or cldn14-/-mice? 2. The data indicate that cldn14 interacts with cldn16, but not cldn19. However, as stated on p9 (but unsupported by data) "The TJ localization of cldn16 or cldn19 was not affected by cldn14 expression". This raises several concerns in the interpretation of the mechanism of action for cldn14, since that authors previous publications demonstrate that cldn16 and cldn19 form obligate heteromers that are required for proper trafficking and assembly of these proteins into tight junctions. Specifically: -It is essential that the authors show immunofluorescence images of the trafficking of cldn14, cldn16 and cldn19 in all of the different LLC-PK1 transfected cell models described in Table 2. -Does cldn14 form a complex with cldn16 and cldn19 or does it interfere with the ability of cldn16 and cldn19 to interact? This can be readily addressed by co-immunoprecipitation analysis of cells expressing all three of these proteins. Figure 2F . The prediction would be that increasing calcium should increase cldn14 protein. Also, cells treated with CaSR siRNA would be predicted to have increased cldn14 expression at baseline as opposed to control siRNA treated cells. Figure 1 , expression driven by the cldn14 promoter appeared restricted to TAL (based on THP staining), however, in the analysis of dissected sections there appeared to be cldn14 mRNA present at substantial levels in other aspects of the kidney (e.g. glomeruli). Cldn14 expression in other areas of the kidney is also consistent with previously published histologic analysis in the paper by Ben Yosef et al. The authors need to present histological analysis of bgal expression in structures beyond the TAL. Also, are the microdissected elements cross contaminated? Analysis of marker mRNAs would strengthen the analysis in Figure 1C . Figure 5E suggest a trend towards increased cldn14 expression in the presence of 10 nM PTH. In the absence of a full dose response, it is premature to state that PTH has no effect on cldn14 expression by MKTAL cells.
In

The data in
6. In Figure 3B , the cldn1 and occludin controls are important as irrelevant antibody controls since these proteins are not expressed by HEK293 cells. However, the way the data is presented, it is easy to get the impression that cldn14 does not interact with either cldn1 or occludin. I suggest relabeling these lanes in the Figure as "non-specific" control and supplying more detail in the figure legend.
7. The title potentially overstates the relative importance of miRNA vs direct control of cldn14 transcription. Also, the title suggests that roles for cldn14 in renal calcium homeostasis were directly assessed, which was not the case.
Referee #3
Comments to the authors:
The manuscript by Gong et al. shows novel and fascinating data on the role of claudin 14 in the kidney and how it is involved in the diet-dependent regulation of Ca2+ transport in the thick ascending limb of Henle. The work is timely and relevant for a broad readership.
The authors made several important and exciting observations that are of interest for scientists working in the fields of cell biology, physiology, renal transport, and nephrology: i) Claudin-14 physically interacts with claudin-16. ii) By this interaction, claudin-14 is reducing the cation permeability of claudin-16/claudin-19 channels. As a consequence, paracellular Ca2+ and Mg2+ transport is decreased. iii) Protein expression of claudin-14 appears to be tightly controlled. The authors have identified to microRNAs that are able to repress claudin-14. iv) These microRNAs are controlled via signaling of the Ca2+ sensing receptors. By this mechanism, claudin-14 expression is regulated by the extracellular Ca2+ activity and this allows adaptation of the paracellular reabsorption of Ca2+ and Mg2+ to the physiological needs.
The authors present a large amount of data that are apparently of high quality. The main story is convincing and supported by the data. However, I feel that the authors should further extend their study by the experiments specified in Major points 1 and 2. These experiments will help to further corroborate the data and could broaden the relevance of the study.
Major points 1. Ben-Yosef et al. (2003) have stated that the CLND14 knockout mouse has no renal phenotype. Given your data, it is not surprising that they did not observe a phenotype under control conditions. However, one would expect a relevance of CLND14 at high Ca2+ diet. You should characterize the renal Ca2+ handling of the CLND14 knockout mouse under variable dietary Ca2+ intake. Such data would help to gain important insights into the in vivo significance of your findings.
2. An important finding of your study is the change of CLND14 protein abundance dependent on the dietary Ca2+ intake. You should corroborate your immunofluorescence data ( Figure 5C ) by adding Western blot analysis of TALs. This is important since the value of immunofluorescence for quantitative comparisons is questionable.
3. Please improve the art work of your figures. The data are beautiful and convincing but the quality of some figures needs to be improved and the resolution is not sufficient (see specific comments under "Minor points").
Minor points 4. The title does hardly point to the major finding of the study. I would like to recommend changing the title.
5. The abstract is very short but not easy to read. Please improve it in a way that it is better understandable to the non-expert readership. "The paracellular claudin channel is critical for regulating Ca++ excretion in the kidney." It is not a single type of paracellular channels, the properties of the paracellular pathway vary from segment to segment. Suggestion: "The paracellular claudin channel of the thick ascending limb of Henle (TAL) is critical for Ca++ reabsorption in the kidney."
6. "Here, we show that claudin-14 promoter and transcript are exclusively localized..." The promoter is present in every cell; only its activity is cell type specific.
7. "Dietary Ca++ variations induce profound changes in transcript and protein levels of claudin-14." Which diets? Decrease or increase?
8. "MiR-9 and miR-374 mediate Ca++ signalling to claudin-14 through changes in their own expression." This sentence is hard to understand. Please rephrase the sentence and indicate that high extracellular Ca++ decreases these microRNAs. 9. Please spell out "CaSR".
10. Page 3, line 13: " (ii) generates a lumen-positive diffusion potential as the driving force. CLDN14". I do not agree with this statement. This is only true for the back-diffusion of Na+ in the late TAL (when the urine is sufficiently diluted). Quantitatively, net reabsorption of Na+ occurs across the paracellular pathway of the TAL (decreasing the lumen positive voltage). The reabsorptive flux of cations across the paracellular pathway reduces the lumen-positive voltage. The lumen-positive voltage is predominantly generated by the asymmetrical ion channel activity of TAL cells.
11. Page 3, line 16: "Nevertheless, neither hypercalciuria nor nephrolithiasis has been found in human or transgenic knockout animals with these mutations." Please provide the reference for the knockout mice phenotype. If you refer to the nice Ben-Yosef paper of 2003: I think that the statement in this paper is only correct for control diet. Probably, Ben-Yosef et al. did not perform a dietary challenge to unmask defects of renal Ca2+ handling. Moreover, if you take this sentence seriously: What is the relevance of your findings when knockout animals and patients have no phenotype? And why is there no phenotype? You have several sentences in your manuscript stating something, but often you don't help the reader to interpret and to understand these statements.
12. Page 4: "Here, we have shown that CaSR mediates extracellular Ca++ signaling to gene expression of CLDN14 in the TAL of the kidney." This sentence is hard to understand. Please rephrase it.
13. Page 5, line 2: Please cite also Ben-Yosef et al. (2003) . They showed a beautiful lacZ stain of the kidney in Fig2Y. I think that this image shows labelling of TALs although it was stated that collecting ducts are stained. Figure S1 is not really needed. FEBS letters, 2011 (Mineta et al.) .
Supplementary
Response
Corrected. Reference has been added.
2.
The discussion on the pathway from CaSR to microRNA.
Response
A very good point that suggests future direction. The discussion has been added to page 17, "The regulation of microRNA by CaSR signaling may occur on several layers: microRNA transcription, processing or degradation (Krol et al., 2010) . The promoters of both miR-9 (miR-9-3 locus) and miR-374 genes contain a canonical myc-binding site (E-box: CACGTG). The transcription of miR-9-3 is upregulated by myc in human breast cancer cells (Ma et al., 2010) ; miR-421/-374 cluster is upregulated by myc in Hela cells although miR-374 itself has not been measured (Hu et al., 2010) . Genetic ablation of Dicer, a nuclease required for microRNA processing, in the proximal tubule (Wei et al., 2010) Figure S5 . The data were described on page 11: "The TJ localization of CLDN16 or CLDN19 in mouse kidneys was not affected by dietary Ca ++ variations ( Figure S5 )."
Figure 7: Why is miR-9 significantly up-regulated when Ca 2+ is increased in its concentration?
Response A discussion has been added to page 15, "It was not known what caused the aberrant miR-9 regulation in absence of CaSR. Extracellular Ca ++ induced cell membrane depolarization devoid of intracellular Ca ++ increase normally accompanied by CaSR activation may trigger additional signaling pathways to miR-9. MiR-9 is known to be regulated by several messengers: myc (Ma et al., 2010 ), alcohol (Pietrzykowski et al., 2008 and aldosterone (Wang et al., 2010) ."
5.
Why is the effect increased when mir-9 and mir-379 is co-transfected? Response A discussion has been added to page 8, "The synergistic effect of multiple microRNAs on their common cognate target has been demonstrated by several studies (Gregory et al., 2008; Yoo et al., 2009) . MicroRNA, when bound to its target, triggers mRNA deadenylation through a common deadenylase complex (Huntzinger and Izaurralde, 2011) . If an mRNA is bound with several microRNAs, ablation of a single microRNA would not sufficiently restore the mRNA stability."
Referee #2
Evidence presented indicates that regulation of cldn14 was controlled by serum calcium in vivo and in isolated cell models under control of the CaSR calcium sensing receptor. Cldn14 alters paracellular permeability in a kidney cell line model, LLC-PK1 cells, expressing exogenous cldn16 and cldn19. Biochemical data is presented suggesting that cldn14 interacts with cldn16, but not cldn19. While this partially addresses the mechanism of action for cldn14 to affect calcium transport, the study stops short of identifying how cldn14 alters cldn19 function when co-expressed with cldn16. Also, while cldn14 is shown to affect the electrophysiological properties of transfected LLC-PK1 cells and renal cldn14 in vivo is regulated in response to dietary/serum calcium, direct roles for cldn14 in renal calcium homeostasis in vivo are inferred, rather than directly measured.
Specific Comments
Is renal calcium homeostasis affected in cldn14+/lacZ reporter or cldn14-/-mice? Response
The in vivo analyses of CLDN14 have been an ongoing focus of the lab. Because CLDN14 is endogenously suppressed under normal dietary condition but upregulated by extracellular Ca ++ , our data predict a prominent renal phenotype in CLDN14 KO when fed with high Ca ++ diet. Because CLDN14 inhibited the CLDN16-19 channel, knockout of CLDN14 would generate a renal phenotype opposite to that in CLDN16 KD and CLDN19 KD. This is indeed what we have found. CLDN14 KO mice develop hypermagnesemia, hypomagnesiuria and hypocalciuria under high Ca ++ dietary condition, accompanied by a secondary change in GFR. These critical data are now presented in Table 2 and described under a new subtitle: "CLDN14 is required for regulating Ca ++ excretion in the kidney" on page 12. Table 2 .
The data indicate that cldn14 interacts with cldn16, but not cldn19. However, as stated on p9 (but unsupported by data) "The TJ localization of cldn16 or cldn19 was not affected by cldn14 expression". This raises several concerns in the interpretation of the mechanism of action for cldn14, since that authors previous publications demonstrate that cldn16 and cldn19 form obligate heteromers that are required for proper trafficking and assembly of these proteins into tight junctions. Specifically: -It is essential that the authors show immunofluorescence images of the trafficking of cldn14, cldn16 and cldn19 in all of the different LLC-PK1 transfected cell models described in
Response
The immunofluorescence images for CLDN14, 16 and 19 cellular localization in transfected LLC-PK1 cells have now been shown in Figure S4 . Because triple transfection is the most stringent condition, we focus on this condition without showing doubly transfected cells. Over 90% of triply transfected cells co-express CLDN14, 16 and 19. All three claudins are correctly localized to the tight junction.
In text, the data were described on page 10, "The TJ localization of CLDN16 or CLDN19 was not affected by CLDN14 expression ( Figure S4) ."
According to Referee #1 -point #3, we stained the mouse kidneys receiving dietary Ca ++ changes for CLDN16 and 19 localization. High Ca ++ diet was known to induce CLDN14 gene expression, thus allowing us to determine if CLDN14 protein would affect the TJ localization of CLDN16 and 19 in the kidney. These in vivo data are shown in Figure S5 .
In text, the data were described on page 11, "The TJ localization of CLDN16 or CLDN19 in mouse kidneys was not affected by dietary Ca ++ variations ( Figure S5 )."
-Does cldn14 form a complex with cldn16 and cldn19 or does it interfere with the ability of cldn16 and cldn19 to interact? This can be readily addressed by co-immunoprecipitation analysis of cells expressing all three of these proteins.
Response A very good point and helpful suggestion. We have performed two independent studies: (1) a quantitative Y2H study showing the interaction strength of CLDN14-16 was equal to that of CLDN16-19 ( Figure 3B) ; (2) a Co-IP study of CLDN14-16-19 interaction in triply transfected HEK293 cells. We found that CLDN14 formed an integral complex with CLDN16-19 instead of competing with CLDN19 for binding to CLDN16. These biochemical data are consistent with the immunostaining data that CLDN14 does not affect the TJ localization of CLDN16 or 19.
In text, the Y2H study was described on page 9, "The level of interaction strength between CLDN14 and CLDN16 was equal to that of CLDN16-19 interaction, as quantified with the lacZ reporter ( Figure 3B )."
The Co-IP data were described on page 9, "In triply transfected cells expressing three claudins at the molecular ratio of 1:1:1, anti-CLDN19 antibody now precipitated CLDN14 with similar affinity to anti-CLDN16 antibody (Figure 3E) , suggesting (1) CLDN19 acted through CLDN16 to interact with CLDN14; (2) CLDN14 integrated into the CLDN16-19 complex instead of forming an independent CLDN14-16 complex. Anti-CLDN14 antibody precipitated the same amount of CLDN16 as anti-CLDN19 antibody (Figure 3E) , suggesting (1) CLDN19-16 interaction was not affected in the presence of CLDN14; (2) the interaction strength of CLDN14-16 was equal to that of CLDN19-16, consistent with the Y2H studies ( Figure 3B) . Together, these data indicate that CLDN14, 16 and 19 form an oligomer by utilizing two separate binding sites in CLDN16 to anchor CLDN14 and CLDN19 respectively" Figure 5 D , E, Figure 6 E, F and Figure 7 , which is clearly feasible based on the data presented in Figure 2F . The Figure 5D , Figure 5F and Figure 7B .
The authors need to assess cldn14 protein expression by MKTAL cells to complement the experiments in
In text, the following sentences are added to describe the protein data: On page 11, "High Ca ++ diet (III) increased CLDN14 protein levels by 3.12-fold on densitometric scale (Figure 5D ; normalized to β-actin protein) compared to the basal diet (I)."
On page 12, "CLDN14 protein levels were significantly increased by 2.59-fold in 3mM Ca ++ (p<0.01, n=4; Figure 5F ) compared to control." On page 14, "While extracellular Ca ++ (3mM) increased CLDN14 mRNA levels ( Figure  7A ) and protein levels ( Figure 7B ) by 2.61-fold and 2.20-fold respectively (versus 0.1mM Ca ++ ; p<0.01, n=3) in scrbl-siRNA cells, CaSR-siRNA completely abolished the Ca ++ inducing effect on CLDN14 expression (Figure 7A-B) ." Figure 1, Figure 1C .
In
Response
We answered this point with two experiments: (1) double histological studies of β-gal expression with additional tubular markers: LTL, NCC and AQP2; (2) a new microdissection study now analyzing both CLDN14 and CLDN16 mRNA levels.
Three new tubular markers are now used to rule out the possibility of β-gal expression in PCT/PST (LTL), DCT (NCC) or CNT/CD (AQP2) (Figure S1 ). Glomerulus is negative for β-gal staining ( Figure S1 ). These new data were described on page 5: "but not in glomerulus ( Figure S1 ) or in tubules that were labeled with the Lotus tetragonolobus lectin (LTL: a proximal convoluted/ straight tubule [PCT/PST] marker) or that co-expressed the thiazide-sensitive Na + /Cl − cotransporter (NCC: a distal convoluted tubule [DCT] marker) or aquoporin-2 (AQP2: a connecting tubule/collecting duct [CNT/CD] marker) ( Figure S1 )."
A new microdissection study has been performed. The microdissection criterion is presented in Figure 1B legend. The new measurement of CLDN14 mRNA level is not significantly different from the previous measurement. Because glomerulus and DCT are joined with TAL through macula densa, great care has been taken to avoid including macula densa into glomerulus or DCT fraction. The measurement of CLDN16 mRNA (a marker for TAL) has ruled out the possibility of tubular cross-contamination during microdissection process. There still seems to be a residual amount of CLDN14 mRNA in glomerulus and DCT. A likely reason is the low endogenous level of CLDN14 mRNA in TAL (only 15% of CLDN16 levels) that is suppressed under basal dietary condition and that diminishes the real-time PCR difference of TAL from other segments such as glomerulus or DCT. Figure 5E suggest a trend towards increased cldn14 expression in the presence of 10 nM PTH. In the absence of a full dose response, it is premature to state that PTH has no effect on cldn14 expression by MKTAL cells.
The data in
Response
A full range of PTH doses (0-100nM) have now been tested and shown in Figure  5G . The data were described on page 12, "PTH, however, when supplemented over a range of doses (1nM, 10nM and 100nM), had no significant effect on CLDN14 gene expression in MKTAL cells (n=3; Figure 5G )."
6. In Figure 3B , the cldn1 and occludin controls are important as irrelevant antibody controls since these proteins are not expressed by HEK293 cells. However, the way the data is presented, it is easy to get the impression that cldn14 does not interact with either cldn1 or occludin. I suggest relabeling these lanes in the Figure as " non-specific" control and supplying more detail in the figure legend.
The IP lanes with CLDN1 and occludin have been re-labeled as "non-specific1" and "non-specific2". The details of non-specific antibodies are given in figure legend.
The title potentially overstates the relative importance of miRNA vs direct control of cldn14
transcription. Also, the title suggests that roles for cldn14 in renal calcium homeostasis were directly assessed, which was not the case.
Response
The title has been revised to "Claudin-14 regulates renal Ca ++ transport in response to CaSR signaling via a novel microRNA pathway".
Referee #3
The manuscript by Gong et al. shows Figure 5D , Figure 5F and Figure 7B .
In text, the following sentences are added to describe the protein data:
Response Agreeing with reviewer, because LacZ is blue or dark green, the best color to label THP would be red. We have indeed tried to show THP under red fluorescence channel. However, red fluorescence is not as bright or as sharp as green fluorescence when merged with bright field. Because the antigens probed in this study -THP (Figure 1A) , LTL, NCC and AQP2 ( Figure S1 ) are all localized in the apical membrane while LacZ only labels the nucleus and cytoplasm, there will be hardly any signal overlap on the merged image. The orange background color in Figure 1C has been changed to white. The asterisk is now labeled in black. 
Figure
Response
Changes have been made according to suggestions: (1) the orange graph background color has been changed to gray scale; (2) the same font and font size were used; (3) the error bar of 2C has been recovered; (4) the y-axis starts from 0.
Figure 4: Why do you use italics for the labelling of the y-axis? Response
The italic font has been changed to regular font on y-axis. In addition, the orange background color has been changed to white. Figure Figure S1 is not really needed.
20.
Supplementary
Response
The old Figure S1 has been removed.
